Emergency Hotlines: LANDLINE (+63) 2 911 – 8688

Senate supports DOH’s request to use a chunk of Dengvaxia refund  

by UNTV News   |   Posted on Wednesday, March 14th, 2018

FILE PHOTO: Senator Richard “Dick” Gordon

MANILA, Philippines — The Senate Blue Ribbon Committee supports the Department of Health’s (DOH) intention to use a portion of Sanofi Pasteur’s Dengvaxia refund.

Senator Richard Gordon has even filed a bill on the matter.

DOH wants to utilize P300,000 of the  P1.16-billion refund money for dengue kits and surveillance officers who will monitor the condition of Dengvaxia vaccinees.  — UNTV News & Rescue

Tags: , ,

DOH prepares cases against Sanofi Pasteur

by UNTV News   |   Posted on Wednesday, October 24th, 2018

The controversial dengue vaccine, Dengvaxia


MANILA, Philippines — The Department of Health (DOH) is set to meet with the Office of the Solicitor General (OSG) next week for the development of the case to be filed against the French pharmaceutical giant, Sanofi Pasteur.

“Regularly naman bawa’t may nakikita tayong ebidenysa katulad ng mga bagong pag-aaral ipinadadala natin sa kanila and we’re meeting with them,” said DOH Usec. Eric Domingo.

Meanwhile, a group of health workers, Aksyon Health Workers party-list appealed to the European Union (EU) and the Committee for Medicinal Products for Human Use (CHMP) to consider first the cases of Dengvaxia vaccinees in the Philippines before giving the accreditation to have it available again in the local market.

The group argued that Europe does not belong to dengue-endemic areas unlike the overseas territories of Carribean, Latin America, Southern Africa and neighboring countries in the Western Pacific Region.

The group together with the Coalition for People’s Right to Health and parents of Dengvaxia vaccinees will also write to the EU to have their appeal be noticed and heard.

“Nakakabahala iyan kasi parang hindi kinonsider kung ano iyong nangyari dito sa Pilipinas na na-vaccinate o nabakunahan iyong 800,000 at merong reported deaths,” said Aksyon president Dr. Joseph Carabeo.

“Tila walang kasiguruhan at ang isa lang talaga na klaro na minamadali nila iyong para ma-recover nila iyong kanilang investment. Paano naman ang kaligtasan at kalusugan ng ating mga anak? May nawalan tayo ng ilang mga anak at the prime of  their life hindi basta-basta na  usapin na ito,” he said.

Meanwhile, there are more than 50 cases being studied by the Dengue Investigative Task Force (DITF) to check the medical records and findings of the vaccinees who died.

Aside from the dengue fast lanes, the DOH is also focusing on putting up dengue centers of excellence in the country to give proper medical care to those infected with dengue, especially the children.

DOH plans to start their operation in 2019 with the help of the world health organization

Dengue centers of excellence will be placed in PGH, San Lazaro Hospital, Vicente Sotto Memorial Medical center in Cebu and in Southern Philippines Medical Center in Davao City. — Aiko Miguel | UNTV News & Rescue

Tags: , ,

Study affirms negative effects of Dengvaxia

by UNTV News and Rescue   |   Posted on Thursday, June 14th, 2018

The controversial anti-dengue vaccine, Dengvaxia

The New England Journal of Medicine published an article about the negative effects of the controversial anti-dengue vaccine, Dengvaxia to those who have not contracted the disease prior to inoculation.

According to the article entitled “Impact of Dengue Serostatus on Dengue Vaccine Safety and Efficacy,” the vaccine is effective in protecting the patient from a re-occurrence of dengue. However, to those without prior dengue infection, the vaccine is not recommended as it could lead to severe dengue.

The study focused on the analysis of the dengue vaccine manufactured by Sanofi Pasteur which is Dengvaxia. This means the research study is in conformity with the recommendation of the World Health Organization (WHO) in April that Dengvaxia should not be administered to children without prior exposure to dengue.

In November 2017, Sanofi Pasteur issued a warning saying there is very high possibility of contracting severe dengue if Dengvaxia is received by individuals without prior dengue infection.

Dengvaxia has been administered to nearly 800,000 children in the Philippines under the government’s Dengue immunization program. – UNTV News & Rescue

Tags: , ,

DOH proposes almost P1.5B for Dengvaxia assistance program

by UNTV News and Rescue   |   Posted on Wednesday, May 16th, 2018

FILE PHOTO: Department of Health Secretary Francisco Duque III


QUEZON CITY, Philippines – The House Committee on Appropriations discussed Wednesday, May 16, the proposed allotment of funds for Department of Health’s (DOH) Dengvaxia Assistance Program in accordance with House Bill Number 7449.

Present in the briefing were Health Secretary Francisco Duque III, Budget Secretary Benjamin Diokno, officials from the Public Attorney’s Office (PAO,) and parents of Dengvaxia vaccinees.

DOH presented before the committee its proposed allocation of the almost P1.5 billion fund which will be taken from the P1.61 billion refund from Sanofi Pasteur for the unused Dengvaxia vaccines.

In its proposal, DOH wants to use the said amount to provide medical assistance to Dengvaxia vaccinees (P84M); to fund DOH’s out-patient care package (P776.250M); to support the deployment of nurses for Health Education (P67.8M); proposed active case finding or profiling/navigation of vaccinees (P300M); and procurement of Dengvaxia medical kits (P270M)

However,committee chair Congressman Carlo Nograles opposed DOH’s appropriation of P270 million  for the purchase of medical kits citing that a larger fund is very much necessary to support the medical needs of Dengvaxia vaccinees.

Based on DOH’s records, there are at least 890,000 Dengvaxia vaccinees across the country. Parents of Dengvaxia vaccinees claimed during the briefing that more children injected with Dengvaxia are still unaccounted by health personnel.

In response to this, DOH appeals for the immediate approval of the budget proposal to deploy nurses who would do the profiling and monitoring of Dengvaxia vaccinees.

Budget Secretary Benjamin Diokno, meanwhile, suggested extending the use of funds preferably up to 2019 to accommodate requests from other agencies. — Rey Pelayo | UNTV News & Rescue

Tags: , ,